Company: ZCARW
Filing Date: 2025-03-28
Form Type: DRS
Source: 0001013762-25-003498
Chunk: 416

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-03-28
Form: DRS
Chunk 416
---
 |   |     |         |         |     |         |            |
|:------------------------|:----|:----------|-----------:|:----|:--------|:--|:----|:--------|--------:|:----|:--------|-----------:|
|                         |     | Total     
 Carrying  
 value     |            |     | Level 1 |   |     | Level 2 |         |     | Level 3 |            |
| Assets:                 |     |           |            |     |         |   |     |         |         |     |         |            |
| Assets                  
 held for sale           |     | $         |    923,176 |     | $       | - |     | $       | 923,176 |     | $       |          - |
| Liabilities:            |     |           |            |     |         |   |     |         |         |     |         |            |
| Preferred               
 stock warrant liability |     | $         |  1,190,691 |     | $       | - |     | $       |       - |     | $       |  1,190,691 |
| Notes                   |     |           | 10,944,727 |     |         | - |     |         |       - |     |         | 10,944,727 |
| SSCPN                   |     |           | 17,422,132 |     |         | - |     |         |       - |     |         | 17,422,132 |
| Derivative              
 financial instrument    |     |           | 14,373,856 |     |         | - |     |         |       - |     |         | 14,373,856 |

<div align='center'>F-105

ZOOMCAR HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>

| 34 | Financial Instruments                 
 - Fair Value Measurements (Continued) |

Level 2: The fair value of Assets held for sale not traded in an active market is determined using the quoted prices in markets that are not active or inputs other than the quoted prices that are observable either directly or indirectly considering all the relevant factors of assets.

The Company’s recurring Level 3 financial instruments within the Company’s fair value hierarchy as of March 31, 2024 consist of Company’s Atalaya Note and as of March 31, 2023 consist of